Method and device for sampling and analyzing interstitial fluid and whole blood samples
-
0Associated
Cases -
0Associated
Defendants -
0Accused
Products -
270Forward
Citations -
0
Petitions -
4
Assignments
First Claim
1. A fluid sampling device comprising a body, the body comprising a dermal layer penetration probe having a penetrating end and a communicating end, and an analysis chamber having a proximal and distal end, the analysis chamber having a volume, the sampling device further comprising a pre-chamber having a volume and a first and second end, wherein the pre-chamber is interposed between the penetration probe and the analysis chamber such that the first end of the pre-chamber is adjacent the communicating end of the penetration probe and the second end of the pre-chamber is adjacent the proximal end of the analysis chamber, wherein the volume of the pre-chamber is greater than the volume of the analysis chamber, and wherein the penetration probe is in fluid communication with the analysis chamber such that fluid can flow from the penetration probe toward the analysis chamber.
4 Assignments
0 Petitions

Accused Products

Abstract
The invention disclosed in this application is a method and device for combining the sampling and analyzing of sub-dermal fluid samples, e.g., interstitial fluid or whole blood, in a device suitable for hospital bedside and home use. It is applicable to any analyte that exists in a usefully representative concentration in the fluid, and is especially suited to the monitoring of glucose.
323 Citations
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 7,909,775 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
BODY FLUID SAMPLING DEVICE | ||
Patent #
US 20110009774A1
Filed 09/10/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,914,465 B2
Filed 02/08/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,774 B2
Filed 02/13/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 7,892,183 B2
Filed 07/03/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
DYNAMIC INTEGRATED LANCING TEST STRIP WITH STERILITY COVER | ||
Patent #
US 20110000168A1
Filed 09/16/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,875,047 B2
Filed 01/25/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Diagnostic devices | ||
Patent #
US 7,883,899 B2
Filed 10/08/2003
|
Current Assignee
ZBX CORP.
|
Sponsoring Entity
ZBX CORP.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,778 B2
Filed 04/20/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
DIAGNOSTIC DEVICES | ||
Patent #
US 20110003371A1
Filed 10/08/2003
|
Current Assignee
ZBX CORP.
|
Sponsoring Entity
ZBX CORP.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,909,777 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,901,365 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Fluid sample transport devices and methods | ||
Patent #
US 7,887,494 B2
Filed 09/30/2005
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
System and method for breaking a sterility seal to engage a lancet | ||
Patent #
US 7,935,063 B2
Filed 10/20/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,938,787 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Fluid Sample Transport Devices and Methods | ||
Patent #
US 20110098599A1
Filed 12/31/2010
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,959,582 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,007,446 B2
Filed 10/19/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 7,988,644 B2
Filed 03/21/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
SYSTEM AND METHOD FOR BREAKING A STERILITY SEAL TO ENGAGE A LANCET | ||
Patent #
US 20110178435A1
Filed 03/29/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Dual blade lancing test strip | ||
Patent #
US 8,016,775 B2
Filed 10/19/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
System for withdrawing small amounts of body fluid | ||
Patent #
US 7,993,284 B2
Filed 09/20/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Tissue penetration device | ||
Patent #
US 8,016,774 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 7,981,056 B2
Filed 06/18/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Device and method for variable speed lancet | ||
Patent #
US 7,976,476 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Lancing apparatus | ||
Patent #
US 8,016,773 B2
Filed 07/18/2002
|
Current Assignee
ARKRAY Inc
|
Sponsoring Entity
ARKRAY Inc
|
Tissue penetration device | ||
Patent #
US 7,981,055 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Integrated lancing test strip with retractable lancet | ||
Patent #
US 8,025,628 B2
Filed 02/22/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
SAMPLE MEASUREMENT SYSTEM | ||
Patent #
US 20110174618A1
Filed 09/21/2009
|
Current Assignee
Jabil Circuit Limited
|
Sponsoring Entity
Jabil Circuit Limited
|
Body fluid sampling device | ||
Patent #
US 8,000,762 B2
Filed 08/31/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Diagnostic Devices | ||
Patent #
US 20110189791A1
Filed 11/23/2010
|
Current Assignee
ZBX CORP
|
Sponsoring Entity
ZBX CORP
|
Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties | ||
Patent #
US 7,988,645 B2
Filed 05/03/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus | ||
Patent #
US 8,057,404 B2
Filed 10/11/2006
|
Current Assignee
PHC Holdings Corporation
|
Sponsoring Entity
Panasonic Corporation
|
Method for manufacturing a sterilized lancet integrated biosensor | ||
Patent #
US 8,052,926 B2
Filed 07/25/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,062,231 B2
Filed 10/11/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Rapid blood expression and sampling | ||
Patent #
US 7,766,846 B2
Filed 01/28/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Lancet device having capillary action | ||
Patent #
US 7,803,123 B2
Filed 04/30/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Needle-insertion device | ||
Patent #
US 7,833,170 B2
Filed 12/11/2003
|
Current Assignee
ARKRAY Inc
|
Sponsoring Entity
ARKRAY Inc
|
Methods of determining concentration of glucose | ||
Patent #
US 7,740,581 B2
Filed 09/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Test Sensor with Under-Fill Protection | ||
Patent #
US 20100009455A1
Filed 05/03/2007
|
Current Assignee
Bayer Healthcare LLC
|
Sponsoring Entity
Bayer Healthcare LLC
|
Body fluid sampling device | ||
Patent #
US 7,819,822 B2
Filed 09/06/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
SAMPLING DEVICES AND METHODS UTILIZING BIASED CAPILLARY ACTION | ||
Patent #
US 20100145228A1
Filed 02/16/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Dynamic integrated lancing test strip with sterility cover | ||
Patent #
US 7,815,579 B2
Filed 03/02/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Integrated spot monitoring device with fluid sensor | ||
Patent #
US 7,654,969 B2
Filed 02/05/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Integrated lancing test strip with retractable lancet | ||
Patent #
US 7,695,442 B2
Filed 04/12/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
INTEGRATED LANCING TEST STRIP WITH RETRACTABLE LANCET | ||
Patent #
US 20100145230A1
Filed 02/22/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method, system, and compositions for cell counting and analysis | ||
Patent #
US 7,738,094 B2
Filed 01/22/2008
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
METHOD FOR MANUFACTURING A STERILIZED LANCET INTEGRATED BIOSENSOR | ||
Patent #
US 20090010802A1
Filed 07/25/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Integrated lance and strip for analyte measurement | ||
Patent #
US 7,473,264 B2
Filed 10/14/2005
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
Lifescan Incorporated
|
Integrated lancing test strip with capillary transfer sheet | ||
Patent #
US 7,488,298 B2
Filed 10/08/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Test unit and test system for analyzing body fluids | ||
Patent #
US 20090093735A1
Filed 09/29/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
METHOD AND APPARATUS FOR PIERCING THE SKIN AND DELIVERY OR COLLECTION OF LIQUIDS | ||
Patent #
US 20090099478A1
Filed 03/13/2007
|
Current Assignee
MICROSAMPLE LTD
|
Sponsoring Entity
MICROSAMPLE LTD
|
Blood monitoring system | ||
Patent #
US 7,608,042 B2
Filed 02/01/2005
|
Current Assignee
Intellectual Discovery Co. Ltd.
|
Sponsoring Entity
IntelliDx Inc.
|
INTEGRATED SPOT MONITORING DEVICE WITH FLUID SENSOR | ||
Patent #
US 20090299226A1
Filed 08/12/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Dual blade lancing test strip | ||
Patent #
US 7,625,457 B2
Filed 01/03/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Devices and Methods for Accessing and Analyzing Physiological Fluid | ||
Patent #
US 20080009768A1
Filed 09/20/2007
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
SYSTEM FOR WITHDRAWING SMALL AMOUNTS OF BODY FLUID | ||
Patent #
US 20080009767A1
Filed 09/20/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Devices and methods for accessing and analyzing physiological fluid | ||
Patent #
US 7,343,188 B2
Filed 05/09/2002
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
Lifescan Incorporated
|
Silicon microprobe with integrated biosensor | ||
Patent #
US 20080097171A1
Filed 10/30/2007
|
Current Assignee
Subramanian Kumar, Smart Wilson, Orloff Eugene
|
Sponsoring Entity
Subramanian Kumar, Smart Wilson, Orloff Eugene
|
SAMPLING DEVICE | ||
Patent #
US 20080097241A1
Filed 10/18/2007
|
Current Assignee
California Institute of Technology
|
Sponsoring Entity
California Institute of Technology
|
Integrated spot monitoring device with fluid sensor | ||
Patent #
US 7,351,213 B2
Filed 04/13/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 7,374,544 B2
Filed 12/31/2002
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Pelikan Technologies Inc.
|
INTEGRATED SPOT MONITORING DEVICE WITH FLUID SENSOR | ||
Patent #
US 20080161725A1
Filed 02/05/2008
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Analytical device with lancet and test element | ||
Patent #
US 7,396,334 B2
Filed 08/29/2002
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Fluid Delivery With In Vivo Electrochemical Analyte Sensing | ||
Patent #
US 20080214916A1
Filed 12/21/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method, system, and compositions for cell counting and analysis | ||
Patent #
US 20080212069A1
Filed 01/22/2008
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
BODY FLUID SAMPLING DEVICE | ||
Patent #
US 20070016103A1
Filed 09/06/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Integrated lance and strip for analyte measurement | ||
Patent #
US 7,169,117 B2
Filed 09/20/2005
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
Lifescan Incorporated
|
Method and device for sampling and analyzing interstitial fluid and whole blood samples | ||
Patent #
US 20070017805A1
Filed 06/30/2006
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
BODY FLUID SAMPLING DEVICE | ||
Patent #
US 20070038149A1
Filed 09/05/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method of preventing short sampling of a capillary or wicking fill device | ||
Patent #
US 20070062315A1
Filed 10/09/2006
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Fluid sample transport devices and methods | ||
Patent #
US 20070078313A1
Filed 09/30/2005
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Blood sensor, blood testing apparatus, and method for controlling blood testing apparatus | ||
Patent #
US 20070123803A1
Filed 10/11/2006
|
Current Assignee
PHC Holdings Corporation
|
Sponsoring Entity
PHC Holdings Corporation
|
Wearable, programmable automated blood testing system | ||
Patent #
US 20070123801A1
Filed 11/28/2005
|
Current Assignee
IntelliDx Inc.
|
Sponsoring Entity
IntelliDx Inc.
|
DUAL BLADE LANCING TEST STRIP | ||
Patent #
US 20070106178A1
Filed 01/03/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
SYSTEM AND METHOD FOR BREAKING A STERILITY SEAL TO ENGAGE A LANCET | ||
Patent #
US 20070167869A1
Filed 10/20/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
System for withdrawing small amounts of body fluid | ||
Patent #
US 7,288,073 B2
Filed 08/30/2001
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and Apparatus for Sampling and Analysis of Fluids | ||
Patent #
US 20070232956A1
Filed 09/13/2005
|
Current Assignee
MICROSAMPLE LTD.
|
Sponsoring Entity
MICROSAMPLE LTD.
|
Silicon microprobe with integrated biosensor | ||
Patent #
US 7,310,543 B2
Filed 03/26/2001
|
Current Assignee
KUMETRIX INC.
|
Sponsoring Entity
KUMETRIX INC.
|
Integrated lance and strip for analyte measurement | ||
Patent #
US 20060030789A1
Filed 10/14/2005
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator | ||
Patent #
US 20060025662A1
Filed 09/29/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Blood monitoring system | ||
Patent #
US 20060079809A1
Filed 02/01/2005
|
Current Assignee
Intellectual Discovery Co. Ltd.
|
Sponsoring Entity
Intellectual Discovery Co. Ltd.
|
Integrated lancing test strip with capillary transfer sheet | ||
Patent #
US 20060079810A1
Filed 10/08/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Integrated lance and strip for analyte measurement | ||
Patent #
US 20060074351A1
Filed 09/20/2005
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Integrated spot monitoring device with fluid sensor | ||
Patent #
US 20060100542A9
Filed 04/13/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method of preventing short sampling of a capillary or wicking fill device | ||
Patent #
US 7,043,821 B2
Filed 04/03/2003
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Methods of fabricating physiological sample collection devices | ||
Patent #
US 7,060,192 B2
Filed 05/09/2002
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
Lifescan Incorporated
|
Needle-insertion device | ||
Patent #
US 20060129065A1
Filed 12/11/2003
|
Current Assignee
ARKRAY Inc
|
Sponsoring Entity
ARKRAY Inc
|
Dynamic integrated lancing test strip with sterility cover | ||
Patent #
US 20060200045A1
Filed 03/02/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Integrated lancing test strip with retractable lancet | ||
Patent #
US 20060229532A1
Filed 04/12/2005
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method of preventing short sampling of a capillary or wicking fill device | ||
Patent #
US 7,131,342 B2
Filed 04/03/2003
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Electrochemical test strip with an integrated micro-needle and associated methods | ||
Patent #
US 7,144,495 B2
Filed 08/23/2002
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
Lifescan Incorporated
|
BODY FLUID SAMPLING DEVICE | ||
Patent #
US 20060293611A1
Filed 08/31/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and device for sampling and analyzing interstitial fluid and whole blood samples | ||
Patent #
US 20050010137A1
Filed 08/10/2004
|
Current Assignee
Chambers Garry, Ron Chatelier, Hodges Alastair
|
Sponsoring Entity
Chambers Garry, Ron Chatelier, Hodges Alastair
|
Self-powered fluid sampler | ||
Patent #
US 6,840,121 B2
Filed 07/18/2003
|
Current Assignee
University of Florida Research Foundation Incorporated
|
Sponsoring Entity
University of Florida Research Foundation Incorporated
|
Devices and methods relating to electrochemical biosensors | ||
Patent #
US 20050023152A1
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Lancet device having capillary action | ||
Patent #
US 6,866,675 B2
Filed 01/22/2002
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method of preventing short sampling of a capillary or wicking fill device | ||
Patent #
US 20050126915A1
Filed 04/03/2003
|
Current Assignee
Alastair Mcindoe Hodges
|
Sponsoring Entity
Alastair Mcindoe Hodges
|
Integrated spot monitoring device with fluid sensor | ||
Patent #
US 20050234368A1
Filed 04/13/2005
|
Current Assignee
Daniel Wong, Wiegel Christopher D.
|
Sponsoring Entity
Daniel Wong, Wiegel Christopher D.
|
Fluid sampling, analysis and delivery system | ||
Patent #
US 20050228313A1
Filed 12/03/2004
|
Current Assignee
University Technologies International Inc.
|
Sponsoring Entity
University Technologies International Inc.
|
Electrochemical coagulation assay and device | ||
Patent #
US 20040011672A1
Filed 07/14/2003
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Method of preventing short sampling of a capillary or wicking fill device | ||
Patent #
US 20040040394A1
Filed 04/04/2003
|
Current Assignee
Alastair Mcindoe Hodges
|
Sponsoring Entity
Alastair Mcindoe Hodges
|
Sampling devices and methods utilizing biased capillary action | ||
Patent #
US 20040122339A1
Filed 12/10/2003
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Self-powered fluid sampler | ||
Patent #
US 20040123681A1
Filed 07/18/2003
|
Current Assignee
University of Florida Research Foundation Incorporated
|
Sponsoring Entity
University of Florida Research Foundation Incorporated
|
Integrated lance and strip for analyte measurement | ||
Patent #
US 20040193202A1
Filed 06/11/2003
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
-
|
Piercing device | ||
Patent #
US 20040215224A1
Filed 01/15/2004
|
Current Assignee
ARKRAY Inc
|
Sponsoring Entity
-
|
Method and device for sampling and analyzing interstitial fluid and whole blood samples | ||
Patent #
US 20040236250A1
Filed 02/13/2003
|
Current Assignee
Chambers Garry, Ron Chatelier, Hodges Alastair
|
Sponsoring Entity
Chambers Garry, Ron Chatelier, Hodges Alastair
|
Method of preventing short sampling of a capillary or wicking fill device | ||
Patent #
US 6,823,750 B2
Filed 04/04/2003
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
System for withdrawing small amounts of body fluid | ||
Patent #
US 20030018282A1
Filed 08/30/2001
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Analytical device with lancet and test element | ||
Patent #
US 20030050573A1
Filed 08/29/2002
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Electrochemical test strip with an integrated micro-needle and associated methods | ||
Patent #
US 20030150745A1
Filed 08/23/2002
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Micro-needles and methods of manufacture and use thereof | ||
Patent #
US 20030208138A1
Filed 04/16/2003
|
Current Assignee
Olson Lorin
|
Sponsoring Entity
-
|
Devices and methods for accessing and analyzing physiological fluid | ||
Patent #
US 20030212347A1
Filed 05/09/2002
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Methods of fabricating physiological sample collection devices | ||
Patent #
US 20030212346A1
Filed 05/09/2002
|
Current Assignee
LifeScan IP Holdings LLC
|
Sponsoring Entity
LifeScan IP Holdings LLC
|
Lancet device having capillary action | ||
Patent #
US 20020103499A1
Filed 01/22/2002
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Silicon microprobe with integrated biosensor | ||
Patent #
US 20020137998A1
Filed 03/26/2001
|
Current Assignee
KUMETRIX INC.
|
Sponsoring Entity
KUMETRIX INC.
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,123,700 B2
Filed 06/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
MULTIPHASE CONTACT AND DISTRIBUTION APPARATUS FOR HYDROPROCESSING | ||
Patent #
US 20120014849A1
Filed 07/19/2010
|
Current Assignee
Chevron USA Incorporated
|
Sponsoring Entity
Chevron USA Incorporated
|
Methods for analyte sensing and measurement | ||
Patent #
RE43187E1
Filed 10/09/2008
|
Current Assignee
WaveForm Technologies Inc.
|
Sponsoring Entity
Isense Corporation
|
Fluid access interface | ||
Patent #
US 8,092,385 B2
Filed 05/23/2006
|
Current Assignee
Intellectual Discovery Co. Ltd.
|
Sponsoring Entity
IntelliDx Inc.
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,079,960 B2
Filed 10/10/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
BLOOD SENSOR, BLOOD TESTING APPARATUS, AND METHOD FOR CONTROLLING BLOOD TESTING APPARATUS | ||
Patent #
US 20120022352A1
Filed 10/04/2011
|
Current Assignee
Panasonic Healthcare Company Limited
|
Sponsoring Entity
Panasonic Healthcare Company Limited
|
Sampling devices and methods utilizing biased capillary action | ||
Patent #
US 8,083,688 B2
Filed 02/16/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for sampling and analysis of fluids | ||
Patent #
US 8,092,394 B2
Filed 09/13/2005
|
Current Assignee
MICROSAMPLE LTD.
|
Sponsoring Entity
MICROSAMPLE LTD.
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,157,748 B2
Filed 01/10/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,162,853 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Body fluid sampling device | ||
Patent #
US 8,162,854 B2
Filed 09/05/2006
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Integrated spot monitoring device with fluid sensor | ||
Patent #
US 8,187,205 B2
Filed 08/12/2009
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,421 B2
Filed 07/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,197,423 B2
Filed 12/14/2010
|
Current Assignee
Pelikan Technologies Inc.
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Tissue penetration device | ||
Patent #
US 8,206,317 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,206,319 B2
Filed 08/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,211,037 B2
Filed 12/22/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,216,154 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,221,334 B2
Filed 12/22/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,235,915 B2
Filed 12/18/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,251,921 B2
Filed 06/10/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Lancet device having capillary action | ||
Patent #
US 8,257,276 B2
Filed 02/18/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for fluid injection | ||
Patent #
US 8,262,614 B2
Filed 06/01/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for body fluid sampling with hybrid actuation | ||
Patent #
US 8,267,870 B2
Filed 05/30/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for an improved sample capture device | ||
Patent #
US 8,282,576 B2
Filed 09/29/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge | ||
Patent #
US 8,282,577 B2
Filed 06/15/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method of manufacturing a fluid sampling device with improved analyte detecting member configuration | ||
Patent #
US 8,296,918 B2
Filed 08/23/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Integrated lancing test strip with retractable lancet | ||
Patent #
US 8,328,737 B2
Filed 09/08/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Tissue penetration device | ||
Patent #
US 8,333,710 B2
Filed 10/05/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,421 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,419 B2
Filed 10/04/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,337,420 B2
Filed 03/24/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,343,075 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Diagnostic devices | ||
Patent #
US 8,349,618 B2
Filed 11/23/2010
|
Current Assignee
ZBX CORP
|
Sponsoring Entity
ZBX CORP
|
Tissue penetration device | ||
Patent #
US 8,360,991 B2
Filed 12/23/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,360,992 B2
Filed 11/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Arrangement for body fluid sample extraction | ||
Patent #
US 8,360,994 B2
Filed 08/03/2011
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method for body fluid sample extraction | ||
Patent #
US 8,360,993 B2
Filed 08/03/2011
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,366,637 B2
Filed 12/03/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Body fluid sampling device | ||
Patent #
US 8,369,918 B2
Filed 06/23/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for body fluid sampling and analyte sensing | ||
Patent #
US 8,372,016 B2
Filed 09/30/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Multiphase contact and distribution apparatus for hydroprocessing | ||
Patent #
US 8,372,354 B2
Filed 07/19/2010
|
Current Assignee
Chevron USA Incorporated
|
Sponsoring Entity
Chevron USA Incorporated
|
Fully integrated wearable or handheld monitor | ||
Patent #
US 8,382,681 B2
Filed 09/29/2006
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,382,682 B2
Filed 02/06/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,382,683 B2
Filed 03/07/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
System for withdrawing small amounts of body fluid | ||
Patent #
US 8,388,552 B2
Filed 06/30/2011
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Method and apparatus for multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,388,551 B2
Filed 05/27/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,403,864 B2
Filed 05/01/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,414,503 B2
Filed 03/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a multi-use body fluid sampling device with sterility barrier release | ||
Patent #
US 8,430,828 B2
Filed 01/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,435,190 B2
Filed 01/19/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Apparatus and method for penetration with shaft having a sensor for sensing penetration depth | ||
Patent #
US 8,439,872 B2
Filed 04/26/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,491,500 B2
Filed 04/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 8,496,601 B2
Filed 04/16/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Devices and methods relating to electrochemical biosensors | ||
Patent #
US 8,506,775 B2
Filed 06/18/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Analytical device with lancet and test element | ||
Patent #
US 8,523,784 B2
Filed 04/30/2004
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Methods of determining analyte concentration | ||
Patent #
US 8,532,731 B2
Filed 05/08/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,556,829 B2
Filed 01/27/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,562,545 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a multi-use body fluid sampling device with analyte sensing | ||
Patent #
US 8,574,168 B2
Filed 03/26/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 8,574,895 B2
Filed 12/30/2003
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,579,831 B2
Filed 10/06/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,622,930 B2
Filed 07/18/2011
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,202,231 B2
Filed 04/23/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,636,673 B2
Filed 12/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Sampling module device and method | ||
Patent #
US 8,641,643 B2
Filed 04/27/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 8,641,644 B2
Filed 04/23/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 8,668,656 B2
Filed 12/31/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,679,033 B2
Filed 06/16/2011
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,690,796 B2
Filed 09/29/2006
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for analyte measurement test time | ||
Patent #
US 8,652,831 B2
Filed 03/26/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Electric lancet actuator | ||
Patent #
US 8,721,671 B2
Filed 07/06/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Integrated spot monitoring device with fluid sensor | ||
Patent #
US 8,747,335 B2
Filed 04/30/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Fluid transfer system and method | ||
Patent #
US 8,753,290 B2
Filed 03/24/2010
|
Current Assignee
Intellectual Discovery Co. Ltd.
|
Sponsoring Entity
Intellectual Inspiration LLC
|
Body fluid sampling device with a capacitive sensor | ||
Patent #
US 8,784,335 B2
Filed 07/25/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Integrated sample acquisition and analyte measurement device | ||
Patent #
US 8,795,176 B2
Filed 07/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Catalysts for body fluid sample extraction | ||
Patent #
US 8,795,201 B2
Filed 01/28/2013
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Devices and methods for facilitating fluid transport | ||
Patent #
US 8,801,631 B2
Filed 09/30/2005
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Methods and apparatus for penetrating tissue | ||
Patent #
US 8,808,201 B2
Filed 01/15/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Body fluid sampling device | ||
Patent #
US 8,814,808 B2
Filed 09/10/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
System for withdrawing small amounts of body fluid | ||
Patent #
US 8,821,413 B2
Filed 02/20/2013
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Operations Incorporated
|
Printable hydrogels for biosensors | ||
Patent #
US 8,828,203 B2
Filed 05/20/2005
|
Current Assignee
Sanofi S.A.
|
Sponsoring Entity
Sanofi S.A.
|
Method for penetrating tissue | ||
Patent #
US 8,845,549 B2
Filed 12/02/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,845,550 B2
Filed 12/03/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Sampling plate | ||
Patent #
US 8,894,832 B2
Filed 03/30/2011
|
Current Assignee
Jabil Circuit Limited
|
Sponsoring Entity
Jabil Circuit Limited
|
Method and apparatus for penetrating tissue | ||
Patent #
US 8,905,945 B2
Filed 03/29/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Calibration material delivery devices and methods | ||
Patent #
US 8,919,605 B2
Filed 11/30/2010
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for an improved sample capture device | ||
Patent #
US 8,945,910 B2
Filed 06/19/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 8,965,476 B2
Filed 04/18/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Analyte detection devices and methods with hematocrit-volume correction and feedback control | ||
Patent #
US 8,969,097 B2
Filed 02/28/2011
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Sampling plate | ||
Patent #
US 9,011,658 B2
Filed 03/30/2011
|
Current Assignee
Jabil Circuit Limited
|
Sponsoring Entity
Jabil Circuit Limited
|
Integrated sample acquisition and analyte measurement device | ||
Patent #
US 9,017,259 B2
Filed 08/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Body fluid sampling device | ||
Patent #
US 9,022,952 B2
Filed 03/15/2012
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Fluid delivery with in vivo electrochemical analyte sensing | ||
Patent #
US 9,028,409 B2
Filed 12/21/2007
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method and apparatus using optical techniques to measure analyte levels | ||
Patent #
US 9,034,639 B2
Filed 06/26/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Dynamic integrated lancing test strip with sterility cover | ||
Patent #
US 9,034,250 B2
Filed 09/16/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Body fluid sampling arrangements | ||
Patent #
US 9,060,723 B2
Filed 07/29/2014
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,072,842 B2
Filed 07/31/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Analyte measurement device with a single shot actuator | ||
Patent #
US 9,089,294 B2
Filed 01/16/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,089,678 B2
Filed 05/21/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Analyte concentration detection devices and methods | ||
Patent #
US 9,095,292 B2
Filed 07/30/2012
|
Current Assignee
Sarnoff Corporation
|
Sponsoring Entity
Intuity Medical Inc.
|
Method, system, and compositions for cell counting and analysis | ||
Patent #
US 9,097,640 B2
Filed 08/20/2012
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
User-actuated storage assembly for injection device | ||
Patent #
US 9,125,975 B2
Filed 08/08/2011
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Low pain penetrating member | ||
Patent #
US 9,144,401 B2
Filed 12/12/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,186,468 B2
Filed 01/14/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Analytical device with lancet and test element | ||
Patent #
US 9,215,993 B2
Filed 05/03/2013
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Body fluid sampling module with a continuous compression tissue interface surface | ||
Patent #
US 9,226,699 B2
Filed 11/09/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 9,248,267 B2
Filed 07/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Printable hydrogel for biosensors | ||
Patent #
US 9,261,476 B2
Filed 04/01/2014
|
Current Assignee
Sanofi-Aventis SA
|
Sponsoring Entity
Sanofi-Aventis SA
|
Method for integrated sample acquisition and analyte measurement device | ||
Patent #
US 9,271,669 B2
Filed 04/27/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Tissue penetration device | ||
Patent #
US 9,314,194 B2
Filed 01/11/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 9,339,612 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a variable user interface | ||
Patent #
US 9,351,680 B2
Filed 10/14/2004
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Analyte detection devices and methods with hematocrit/volume correction and feedback control | ||
Patent #
US 9,366,636 B2
Filed 02/04/2015
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Cam drive for managing disposable penetrating member actions with a single motor and motor and control system | ||
Patent #
US 9,375,169 B2
Filed 01/29/2010
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Multi-site body fluid sampling and analysis cartridge | ||
Patent #
US 9,380,974 B2
Filed 09/29/2006
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for analyte detecting device | ||
Patent #
US 9,386,944 B2
Filed 04/10/2009
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 9,427,532 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Dynamic integrated lancing test strip with sterility cover | ||
Patent #
US 9,445,756 B2
Filed 09/22/2010
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diabetes Care Inc.
|
Method for penetrating tissue | ||
Patent #
US 9,498,160 B2
Filed 09/29/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Methods and systems for detecting an analyte in a sample | ||
Patent #
US 9,523,682 B2
Filed 11/16/2012
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means | ||
Patent #
US 9,560,993 B2
Filed 12/20/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for improving fluidic flow and sample capture | ||
Patent #
US 9,561,000 B2
Filed 12/10/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Detection meter and mode of operation | ||
Patent #
US 9,636,051 B2
Filed 06/08/2009
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Biological fluid micro-sample management device | ||
Patent #
US 9,649,061 B2
Filed 03/09/2016
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Integrated sample acquisition and analyte measurement method | ||
Patent #
US 9,662,057 B2
Filed 02/17/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Abbott Diabetes Care Incorporated
|
Low-cost point-of-care assay device | ||
Patent #
US 9,678,065 B2
Filed 01/10/2014
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Blood sample management using open cell foam | ||
Patent #
US 9,693,723 B2
Filed 09/22/2015
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Sampling module device and method | ||
Patent #
US 9,694,144 B2
Filed 12/03/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,724,021 B2
Filed 12/08/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,775,553 B2
Filed 10/01/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Devices and methods for body fluid sampling and analysis | ||
Patent #
US 9,782,114 B2
Filed 08/03/2012
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,795,334 B2
Filed 07/09/2007
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,795,747 B2
Filed 06/02/2011
|
Current Assignee
Pelikan Technologies Inc.
|
Sponsoring Entity
Pelikan Technologies Inc.
|
Microfluidic devices, and methods of making and using the same | ||
Patent #
US 9,797,899 B2
Filed 11/05/2014
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Methods and apparatus for lancet actuation | ||
Patent #
US 9,802,007 B2
Filed 11/18/2013
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Method and apparatus for a fluid sampling device | ||
Patent #
US 9,820,684 B2
Filed 06/03/2005
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Body fluid sampling device—sampling site interface | ||
Patent #
US 9,833,183 B2
Filed 06/01/2009
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Body fluid sampling arrangements | ||
Patent #
US 9,839,384 B2
Filed 06/18/2015
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Body fluid sampling device with capacitive sensor | ||
Patent #
US 9,839,386 B2
Filed 06/12/2014
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Biological fluid micro-sample management device | ||
Patent #
US 9,873,117 B2
Filed 04/11/2017
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Calibration material delivery devices and methods | ||
Patent #
US 9,897,610 B2
Filed 12/01/2014
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for penetrating tissue | ||
Patent #
US 9,907,502 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Tissue penetration device | ||
Patent #
US 9,937,298 B2
Filed 12/16/2008
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Optical imaging system and methods for using the same | ||
Patent #
US 10,018,640 B2
Filed 11/10/2014
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
User-actuated storage assembly for injection device | ||
Patent #
US 10,029,042 B2
Filed 08/24/2015
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Low pain penetrating member | ||
Patent #
US 10,034,628 B2
Filed 12/20/2012
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Sponsoring Entity
Sanofi-Aventis Deutschland GmbH
|
Microfluidic devices, and methods of making and using the same | ||
Patent #
US 10,073,093 B2
Filed 09/13/2017
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Blood sample management using open cell foam | ||
Patent #
US 10,219,731 B2
Filed 06/02/2017
|
Current Assignee
Becton Dickinson Co
|
Sponsoring Entity
Becton Dickinson Co
|
Analyte detection devices and methods with hematocrit/volume correction and feedback control | ||
Patent #
US 10,226,208 B2
Filed 06/08/2016
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Analyte monitoring methods and systems | ||
Patent #
US 10,330,667 B2
Filed 06/24/2011
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Medical diagnostic devices and methods | ||
Patent #
US 10,383,556 B2
Filed 06/08/2009
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Devices and methods for facilitating fluid transport | ||
Patent #
US 10,433,780 B2
Filed 07/01/2014
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Multi-site body fluid sampling and analysis cartridge | ||
Patent #
US 10,441,205 B2
Filed 06/23/2016
|
Current Assignee
Intuity Medical Inc.
|
Sponsoring Entity
Intuity Medical Inc.
|
Method and apparatus for obtaining blood for diagnostic tests | ||
Patent #
US 6,206,841 B1
Filed 04/11/2000
|
Current Assignee
Abbott Laboratories Incorporated
|
Sponsoring Entity
Abbott Laboratories Incorporated
|
Interstitial fluid collection and constituent measurement | ||
Patent #
US 6,080,116 A
Filed 10/09/1998
|
Current Assignee
Integ Incorporated
|
Sponsoring Entity
Integ Incorporated
|
Diagnostic assay requiring a small sample of biological fluid | ||
Patent #
US 6,077,660 A
Filed 06/10/1998
|
Current Assignee
Abbott Laboratories Incorporated
|
Sponsoring Entity
Abbott Laboratories Incorporated
|
Needle assembly for fluid sampler | ||
Patent #
US 6,120,464 A
Filed 10/16/1998
|
Current Assignee
Integ Incorporated
|
Sponsoring Entity
Integ Incorporated
|
Small volume in vitro analyte sensor | ||
Patent #
US 6,143,164 A
Filed 12/16/1998
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Sponsoring Entity
Therasense Incorporated
|
Enhanced interstitial fluid collection | ||
Patent #
US 5,879,367 A
Filed 09/08/1995
|
Current Assignee
Integ Incorporated
|
Sponsoring Entity
-
|
Body fluid sampler | ||
Patent #
US 5,879,310 A
Filed 09/06/1996
|
Current Assignee
Integ Incorporated
|
Sponsoring Entity
-
|
Thin reaction chambers for containing and handling liquid microvolumes | ||
Patent #
US 5,922,604 A
Filed 06/05/1997
|
Current Assignee
Gene Tec Corporation
|
Sponsoring Entity
-
|
Electrochemical method | ||
Patent #
US 5,942,102 A
Filed 05/07/1997
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
-
|
Methods and apparatus for sampling and analyzing body fluid | ||
Patent #
US 5,951,492 A
Filed 05/16/1997
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
-
|
Methods for testing the concentration of an analyte in a body fluid | ||
Patent #
US 5,962,215 A
Filed 04/05/1996
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
AMIRA MEDICAL
|
Electrochemical biosensor test strip | ||
Patent #
US 5,997,817 A
Filed 12/05/1997
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Roche Diagnostics Corporation
|
Test apparatus and method for testing cuvette accommodated samples | ||
Patent #
US 5,731,212 A
Filed 12/20/1994
|
Current Assignee
International Technidyne Corporation
|
Sponsoring Entity
International Technidyne Corporation
|
Interstitial fluid collection and constituent measurement | ||
Patent #
US 5,820,570 A
Filed 08/27/1997
|
Current Assignee
Integ Incorporated
|
Sponsoring Entity
Integ Incorporated
|
Electrochemical sensor | ||
Patent #
US 5,628,890 A
Filed 09/27/1995
|
Current Assignee
Medisense Incorporated
|
Sponsoring Entity
Medisense Incorporated
|
Fluid handling methods for use in mesoscale analytical devices | ||
Patent #
US 5,635,358 A
Filed 02/14/1994
|
Current Assignee
Trustees Of The University Of Pennsylvania
|
Sponsoring Entity
Trustees Of The University Of Pennsylvania
|
Methods and apparatus for electrochemical measurements | ||
Patent #
US 5,645,709 A
Filed 12/07/1994
|
Current Assignee
VAN DEN BERGH FOODS CO. DIVISION OF CONOPCO INC.
|
Sponsoring Entity
VAN DEN BERGH FOODS CO. DIVISION OF CONOPCO INC.
|
Sample collection and manipulation method | ||
Patent #
US 5,700,695 A
Filed 06/30/1994
|
Current Assignee
YASSINZADEH ZIA
|
Sponsoring Entity
YASSINZADEH ZIA
|
Assay method with enzyme electrode system | ||
Patent #
US 5,508,171 A
Filed 02/22/1994
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Boehringer Mannheim Corporation
|
Strip electrode including screen printing of a single layer | ||
Patent #
US 5,509,410 A
Filed 07/27/1994
|
Current Assignee
Medisense Incorporated
|
Sponsoring Entity
Medisense Incorporated
|
Interstitial fluid collection and constituent measurement | ||
Patent #
US 5,582,184 A
Filed 10/11/1994
|
Current Assignee
Integ Incorporated
|
Sponsoring Entity
Integ Incorporated
|
Biosensor and method of quantitative analysis using the same | ||
Patent #
US 5,382,346 A
Filed 10/20/1993
|
Current Assignee
Kyoto Daiichi Kagaku Co. Ltd.
|
Sponsoring Entity
Kyoto Daiichi Kagaku Co. Ltd.
|
Biosensor and method for hematocrit determination | ||
Patent #
US 5,385,846 A
Filed 06/03/1993
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Boehringer Mannheim Corporation
|
Biosensor with a data memory | ||
Patent #
US 5,384,028 A
Filed 08/27/1993
|
Current Assignee
NEC Corporation
|
Sponsoring Entity
NEC Corporation
|
Potentiometric biosensor and the method of its use | ||
Patent #
US 5,413,690 A
Filed 07/23/1993
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Boehringer Mannheim Corporation
|
Glucose test strip for whole blood | ||
Patent #
US 5,418,142 A
Filed 10/13/1992
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Electrochemical sensor | ||
Patent #
US 5,437,999 A
Filed 02/22/1994
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Boehringer Mannheim Corporation
|
Visual blood glucose concentration test strip | ||
Patent #
US 5,306,623 A
Filed 07/26/1991
|
Current Assignee
Lifescan Incorporated
|
Sponsoring Entity
Lifescan Incorporated
|
Biosensor and measuring apparatus using the same | ||
Patent #
US 5,320,732 A
Filed 06/11/1993
|
Current Assignee
Matsushita Electric Industrial Company Limited
|
Sponsoring Entity
Matsushita Electric Industrial Company Limited
|
Devices for containing biological specimens for thermal processing | ||
Patent #
US 5,346,672 A
Filed 03/02/1993
|
Current Assignee
Gene Tec Corporation
|
Sponsoring Entity
Gene Tec Corporation
|
Device for testing body fluids | ||
Patent #
US 5,178,831 A
Filed 08/15/1991
|
Current Assignee
Dai Nippon Insatsu Kab Ushiki Kaisha
|
Sponsoring Entity
Dai Nippon Insatsu Kab Ushiki Kaisha
|
Biosensor utilizing enzyme and a method for producing the same | ||
Patent #
US 5,192,415 A
Filed 03/02/1992
|
Current Assignee
Matsushita Electric Industrial Company Limited
|
Sponsoring Entity
Matsushita Electric Industrial Company Limited
|
Reaction apparatus employing gravitational flow | ||
Patent #
US 5,225,163 A
Filed 04/22/1992
|
Current Assignee
Angenics Inc.
|
Sponsoring Entity
Angenics Inc.
|
Preparation of biosensor having a layer containing an enzyme, electron acceptor and hydrophilic polymer on an electrode system | ||
Patent #
US 5,229,282 A
Filed 11/26/1990
|
Current Assignee
Matsushita Electric Industrial Company Limited
|
Sponsoring Entity
Matsushita Electric Industrial Company Limited
|
Bioelectrochemical electrodes | ||
Patent #
US 5,126,034 A
Filed 07/21/1989
|
Current Assignee
MEDISENSE INC. CAMBRIDGE MA. A CORP. OF MA.
|
Sponsoring Entity
MEDISENSE INC. CAMBRIDGE MA. A CORP. OF MA.
|
Biosensor and a process for preparation thereof | ||
Patent #
US 5,120,420 A
Filed 11/27/1989
|
Current Assignee
Matsushita Electric Industrial Company Limited
|
Sponsoring Entity
Matsushita Electric Industrial Company Limited
|
Method and apparatus for amperometric diagnostic analysis | ||
Patent #
US 5,128,015 A
Filed 03/13/1989
|
Current Assignee
Roche Diabetes Care Inc.
|
Sponsoring Entity
Boehringer Mannheim Corporation
|
Device for use in chemical test procedures | ||
Patent #
US 5,141,868 A
Filed 11/27/1989
|
Current Assignee
Inverness Medical Switzerland GmbH
|
Sponsoring Entity
Internationale Octrooi Maatschappij Octropa BV
|
Blood separation device comprising a filter and a capillary flow pathway exiting the filter | ||
Patent #
US 5,135,719 A
Filed 10/23/1990
|
Current Assignee
Roche Diagnostics Corporation
|
Sponsoring Entity
Biotrack Inc.
|
Electrochemical measurement cell | ||
Patent #
US 4,900,424 A
Filed 09/28/1988
|
Current Assignee
Inverness Medical Switzerland GmbH
|
Sponsoring Entity
UNILEVER PATENT HOLDINGS B.V. ROCHUSSENSTRAAT 78 ROTTERDAM THE NETHERLANDS A COMPANY OF THE NETHERLANDS
|
A dry reagent delivery system with membrane having porosity gradient | ||
Patent #
US 4,774,192 A
Filed 01/28/1987
|
Current Assignee
Home Diagnostics Incorporated
|
Sponsoring Entity
TECHNIMED CORPORATION
|
Test strip and fixture | ||
Patent #
US 4,790,979 A
Filed 08/29/1986
|
Current Assignee
Home Diagnostics Incorporated
|
Sponsoring Entity
TECHNIMED CORPORATION
|
Cuvette for sampling and analysis | ||
Patent #
US 4,654,197 A
Filed 10/12/1984
|
Current Assignee
Migrata U.K. Limited
|
Sponsoring Entity
AKTIEBOLAGET LEO
|
Glucose medical monitoring system | ||
Patent #
US 4,627,445 A
Filed 04/08/1985
|
Current Assignee
DAYTON JUDSON M., KUDD ARTHUR R.
|
Sponsoring Entity
AUDIOBIONICS
|
Structural configuration for transport of a liquid drop through an ingress aperture | ||
Patent #
US 4,254,083 A
Filed 07/23/1979
|
Current Assignee
Clinical Diagnostic Systems Inc.
|
Sponsoring Entity
Eastman Kodak Company
|
Liquid conductivity measuring system and sample cards therefor | ||
Patent #
US 4,301,412 A
Filed 10/29/1979
|
Current Assignee
United States Surgical Corporation
|
Sponsoring Entity
United States Surgical Corporation
|
Blood sample collector | ||
Patent #
US 4,298,011 A
Filed 09/07/1979
|
Current Assignee
Vanek Chester F., Mangurten Henry H.
|
Sponsoring Entity
Vanek Chester F., Mangurten Henry H.
|
Disposable sample card and method of making same | ||
Patent #
US 4,301,414 A
Filed 10/29/1979
|
Current Assignee
United States Surgical Corporation
|
Sponsoring Entity
United States Surgical Corporation
|
Electrical liquid conductivity measuring system | ||
Patent #
US 4,303,887 A
Filed 10/29/1979
|
Current Assignee
United States Surgical Corporation
|
Sponsoring Entity
United States Surgical Corporation
|
Liquid transport device and method | ||
Patent #
US 4,233,029 A
Filed 10/25/1978
|
Current Assignee
Clinical Diagnostic Systems Inc.
|
Sponsoring Entity
Eastman Kodak Company
|
Apparatus for sampling, mixing the sample with a reagent and making particularly optical analyses | ||
Patent #
US 4,088,448 A
Filed 09/16/1976
|
Current Assignee
MIGRATA U.K. LIMITED A U.K. COMPANY
|
Sponsoring Entity
Lilja Jan E., Nilsson Sven E. L.
|
Device for determining ionic activity of components of liquid drops | ||
Patent #
US 4,053,381 A
Filed 05/19/1976
|
Current Assignee
Eastman Kodak Company
|
Sponsoring Entity
Eastman Kodak Company
|
DIALYZING LIQUID-COLLECTING CONTAINER | ||
Patent #
US 3,640,388 A
Filed 08/20/1970
|
Current Assignee
Damon Corporation
|
Sponsoring Entity
Damon Corporation
|
51 Claims
- 1. A fluid sampling device comprising a body, the body comprising a dermal layer penetration probe having a penetrating end and a communicating end, and an analysis chamber having a proximal and distal end, the analysis chamber having a volume, the sampling device further comprising a pre-chamber having a volume and a first and second end, wherein the pre-chamber is interposed between the penetration probe and the analysis chamber such that the first end of the pre-chamber is adjacent the communicating end of the penetration probe and the second end of the pre-chamber is adjacent the proximal end of the analysis chamber, wherein the volume of the pre-chamber is greater than the volume of the analysis chamber, and wherein the penetration probe is in fluid communication with the analysis chamber such that fluid can flow from the penetration probe toward the analysis chamber.
- 27. A method for determining a presence or an absence of an analyte in a fluid sample comprising the steps of:
providing a fluid sampling device comprising a dermal layer penetration probe having a penetrating end and a communicating end, and an analysis chamber having a proximal and distal end, the analysis chamber having a volume, the fluid sampling device further comprising a pre-chamber having a volume and a first and second end, wherein the pre-chamber is interposed between the penetration probe and the analysis chamber such that the first end of the pre-chamber is adjacent the communicating end of the penetration probe and the second end of the pre-chamber is adjacent the proximal end of the analysis chamber, wherein the volume of the pre-chamber is greater than the volume of the analysis chamber, and wherein the penetration probe is in fluid communication with the analysis chamber such that fluid can flow from the penetration probe toward the analysis chamber;
penetrating a dermal layer with the penetration probe;
substantially filling the analysis chamber with a fluid sample by allowing the sample to flow from the penetration probe toward the analysis chamber; and
detecting a presence or an absence of the analyte within the analysis chamber. - View Dependent Claims (28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)
applying a compressing force to the compressible bladder, to reduce the volume of the compressible bladder; and
releasing the compressing force, to form a partial vacuum in the compressible bladder and analysis chamber.
- 31. The method of
claim 30 , wherein the penetrating step is preceded by the applying step and followed by the releasing step. - 32. The method of
claim 27 , wherein the detecting step comprises a qualitative or quantitative measurement of a characteristic of the sample. - 33. The method of
claim 32 wherein the characteristic of the sample comprises a reaction product of the analyte. - 34. The method of
claim 33 , wherein the reaction product is selected from the group consisting of a color indicator, an electric current, an electric potential, an acid, a base, a precipitate, and a gas. - 35. The method of
claim 27 , wherein the analyte is selected from the group consisting of an ion, an element, a sugar, an alcohol, a hormone, a protein, an enzyme, a cofactor, a nucleic acid sequence, a lipid, a pharmaceutical, and a drug. - 36. The method of
claim 27 , wherein the analyte is selected from the group consisting of potassium ion, ethanol, cholesterol, and lactate. - 37. The method of
claim 27 , wherein the flow of sample toward the analysis chamber is driven by a driving force, wherein the driving force comprises a force selected from the group consisting of a capillary force and a pressure differential. - 38. The method of
claim 37 , wherein the pre-chamber is capable of exerting a first capillary force and the analysis chamber is capable of exerting a second capillary force and wherein a differential exists between the first and the second capillary forces. - 39. The method of
claim 38 , wherein the capillary force exerted by the analysis chamber is greater than the capillary force exerted by the pre-chamber. - 40. The method of
claim 39 , wherein an interior surface of the pre-chamber comprises at least first and second pre-chamber walls spaced apart at a first distance to define a pre-chamber height, and wherein an interior surface of the analysis chamber comprises at least first and second analysis chamber walls spaced apart at a second distance to define an analysis chamber height, wherein the height of the analysis chamber is less than the height of the pre-chamber, and wherein the differential capillary force derives at least in part from a difference between the pre-chamber height and the analysis chamber height. - 41. The method of
claim 39 , wherein at least one of the pre-chamber and analysis chamber comprises a substance capable of enhancing or diminishing a capillary force. - 42. The method of
claim 41 , wherein the substance is selected from the group consisting of a polymer, a resin, a powder, a mesh, a fibrous material, a crystalline material, a porous material, or a combination thereof. - 43. The method of
claim 41 , wherein the substance is selected from the group consisting of polyethylene glycol, polyvinylpyrrolidone, a surfactant, a hydrophilic block copolymer, and polyacrylic acid. - 44. The method of
claim 37 , wherein the pressure differential comprises a positive pressure applied toward the analysis chamber. - 45. The method of
claim 37 , wherein the pressure differential comprises a negative pressure applied from the analysis chamber. - 46. The method of
claim 37 , the pre-chamber further comprising at least one flexible wall and wherein upon compression of the chamber at the flexible wall the volume of the pre-chamber is reduced. - 47. The method of
claim 46 , the pre-chamber further comprising a valve at the first end capable of substantially sealing the pre-chamber from the penetration probe. - 48. The method of
claim 47 , wherein the step of substantially filling the analysis chamber with sample comprises losing the valve and compressing the pre-chamber. - 49. The method of
claim 27 , the analysis chamber further comprising at least one flexible wall and wherein upon compression of the analysis chamber at the flexible wall the volume of the analysis chamber is reduced. - 50. The method of
claim 49 , further comprising the steps of:applying a compressing force to the flexible wall of the analysis chamber to reduce the volume of the analysis chamber; and
releasing the compressing force, to form a partial vacuum in the analysis chamber.
- 51. The method of
claim 50 , wherein the penetrating step is preceded by the applying step and followed by the releasing step.
1 Specification
The present invention relates to a method and device for combining the sampling and analyzing of interstitial fluid or whole blood samples which is suitable for hospital bedside and home use.
The management of many medical conditions requires the measurement and monitoring of a variety of analytes in bodily fluid. Historically, the measurement of analytes in blood has required an invasive technique, such as a venipuncture or finger puncture, to obtain blood for sampling purposes. An example of an analyte which is routinely tested by obtaining a blood sample through an invasive technique is glucose. In order to control their condition, diabetics must monitor their glucose levels on a regular basis. Invasive techniques used to obtain a blood sample for analysis have the disadvantage of being painful, which can reduce patient compliance in regular monitoring. Repeated testing, e.g., on a fingertip, can result in scar tissue build-up which makes obtaining a sample in that region more difficult. Moreover, invasive sampling procedures pose a risk of infection or disease transmission.
An alternative is to sample interstitial fluid rather than whole blood. Interstitial fluid is the fluid that fills the space between the connective tissue and cells of the dermal layer of the skin. An application where interstitial fluid has been shown to be an appropriate sampling substitute for plasma or whole blood is in the measurement of glucose concentration (J. Lab. Clin. Med. 1997, 130, 436-41).
In the patents U.S. Pat. Nos. 5,879,367, 5,879,310, 5,820,570 and 5,582,184 are disclosed methods of sampling using a fine needle in conjunction with a device to limit the penetration depth to obtain small volumes of interstitial fluid for the purpose of glucose monitoring. However, there is no method disclosed for analyzing the drawn samples that is suitable for home use or hospital bedside use.
It is desirable to be able to measure the concentration of analytes in humans or other animals without having to draw a blood sample by conventional methods. It is further desirable to be able to do so with an inexpensive disposable device that is simple enough for home or hospital bedside use.
The invention provides a suitable alternative to conventional sampling devices and methods that is less invasive than traditional whole blood sampling techniques and that requires a considerably smaller sample volume than is required in the conventional venipuncture or finger puncture sampling methods. Because of the smaller sample volume required, a smaller wound is necessary to obtain the sample. In the conventional finger stick method, a drop of blood is formed on the tip of a finger, then the sensor sample entrance is wetted with the drop. Because the sample comes into contact with the skin surface, contamination of the sample by material on the skin surface is possible. The devices and methods disclosed herein do not require forming a blood drop on the surface of the skin, and therefore have less risk of sample contamination.
In one embodiment of the present invention, a fluid sampling device is provided which includes a body, the body including a dermal layer penetration probe having a penetrating end and a communicating end, and an analysis chamber having a proximal and distal end, the analysis chamber having a volume, wherein the penetration probe is in fluid communication with the analysis chamber such that fluid can flow from the penetration probe toward the analysis chamber. The analysis chamber can have at least one flexible wall which can be compressed to reduce the volume of the analysis chamber. The penetration probe can include, for example, a needle, a lancet, a tube, a channel, or a solid protrusion and can be constructed of a material such as carbon fiber, boron fiber, plastic, metal, glass, ceramic, a composite material, mixtures thereof, and combinations thereof. The penetration probe can include two sheets of material in substantial registration, having a protrusion on each sheet, wherein the sheets are spaced apart such that liquid can be drawn between the sheets by capillary action. The two sheets of material can extend into the device so as to form a pre-chamber. The penetration probe can be positioned within a recess in the proximal end of the device, and the recess can be configured to substantially align with a shape of a selected dermal surface.
In a further embodiment, the device can further include a pre-chamber having a volume and a first and second end, wherein the pre-chamber is interposed between the penetration probe and the analysis chamber such that the first end of the pre-chamber is adjacent the communicating end of the penetration probe and the second end of the pre-chamber is adjacent the proximal end of the analysis chamber. The volume of the pre-chamber can be greater than or equal to the volume of the analysis chamber. The pre-chamber can have at least one flexible wall that can be compressed to reduce the volume of the pre-chamber. The pre-chamber can also include a valve at the first end capable of substantially sealing the pre-chamber from the penetration probe.
In another embodiment, the device further includes a compressible bladder in communication with the analysis chamber, the compressible bladder being capable of applying a positive or a negative pressure to the analysis chamber.
In yet another embodiment, the pre-chamber and the analysis chamber can be capable of exerting different capillary forces. The capillary force exerted by the analysis chamber can be greater than the capillary force exerted by the pre-chamber. The differential capillary force can be derived, at least in part, from a difference between the pre-chamber height and the analysis chamber height. In this embodiment, the interior surface of the pre-chamber can include at least first and second pre-chamber walls spaced apart at a first distance to define a pre-chamber height, and the interior surface of the analysis chamber can include at least first and second analysis chamber walls spaced apart at a second distance to define an analysis chamber height, wherein the height of the analysis chamber is less than the height of the pre-chamber.
In yet another further embodiment, at least one of the chambers can include a substance capable of enhancing or diminishing the capillary force exerted by the chamber. The substance can include, for example, a polymer, a resin, a powder, a mesh, a fibrous material, a crystalline material, or a porous material. Suitable substances include polyethylene glycol, polyvinylpyrrolidone, a surfactant, a hydrophilic block copolymer, and polyvinylacetate. In a further embodiment, the device further includes a releasable actuator capable of supplying a force sufficient to cause the penetration probe to penetrate a dermal layer. The actuator can be external to or integral with the body, and upon release propels the body toward the dermal layer.
In a further embodiment, the analysis chamber can include an electrochemical cell including a working electrode and a counter/reference electrode and an interface for communication with a meter, wherein the interface communicates a voltage or a current.
In yet another embodiment of the present invention, a method for determining a presence or an absence of an analyte in a fluid sample is provided including the steps of providing a fluid sampling device as described above; penetrating a dermal layer with the penetration probe; substantially filling the analysis chamber with a fluid sample by allowing the sample to flow from the penetration probe toward the analysis chamber; and detecting a presence or an absence of the analyte within the analysis chamber. The sample can include, for example, interstitial fluid and whole blood. A qualitative or quantitative measurement of a characteristic of the sample can be obtained in the detecting step. The characteristic of the sample can include, for example, a reaction product of the analyte, such as a color indicator, an electric current, an electric potential, an acid, a base, a reduced species, a precipitate, and a gas. The analyte can include, for example, an ion such as potassium, an element, a sugar, an alcohol such as ethanol, a hormone, a protein, an enzyme, a cofactor, a nucleic acid sequence, a lipid, a pharmaceutical, and a drug. Cholesterol and lactate are examples of substances that can be analyzed.
In a further embodiment, the flow of sample toward the analysis chamber can be driven by a driving force, e.g., capillary force or a pressure differential. Where the analysis chamber has a flexible wall, the wall can be compressed to reduce the volume of the analysis chamber prior to penetrating the dermal, then the compression released to form a partial vacuum in the analysis chamber. Where the fluid sampling device further includes a compressible bladder, the bladder can be compressed to reduce its volume, then after penetration of the dermal layer the compression can be released to form a partial vacuum in the compressible bladder and analysis chamber. dr
FIG. 1 shows a top view (not to scale) of one embodiment of a sampling device illustrating an arrangement of the penetration probe, pre-chamber, and analysis chamber.
FIG. 2 shows a cross section (not to scale) along the line A-A′ of FIG. 1.
FIG. 3 shows a top view (not to scale) of one embodiment of a sampling device illustrating an arrangement of the penetration probe, pre-chamber, and analysis chamber wherein the proximal edge of the device forms a recess.
FIG. 4 shows a top view (not to scale) of one embodiment of a sampling device illustrating an arrangement of the penetration probe, pre-chamber, and analysis chamber.
FIG. 5 shows a cross section (not to scale) along the line B-B′ of FIG. 4.
FIGS. 6a and 6b (not to scale) depict an embodiment of the invention wherein the device is loaded in a releasable actuator to facilitate penetration of a dermal layer by the penetration probe. FIG. 6a depicts the device loaded in the actuator, wherein the actuator is in the cocked position, ready to be triggered. FIG. 6b depicts the device and actuator after triggering.
Introduction
The following description and examples illustrate various embodiments of the present invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a preferred embodiment should not be deemed to limit the scope of the present invention. Methods and devices for optimizing sampling of fluid samples are discussed further in copending U.S. patent application Ser. No. 09/536,234, filed on even date herewith, entitled “METHOD OF PREVENTING SHORT SAMPLING OF A CAPILLARY OR WICKING FILL DEVICE,” which is incorporated herein by reference in its entirety.
The invention disclosed in this application is a method and device for combining the sampling and analyzing of a fluid sample from sub-dermal tissue in a device suitable for hospital bedside and home use. The fluid sample can comprise, but is not limited to, interstitial fluid or whole blood samples obtained from an animal. Any fluid sample obtained from sub-dermal tissue of a plant or an animal can sampled and analyzed, thus the invention has broad application in the fields of human medicine, veterinary medicine, and horticultural science. The device and method are applicable to any analyte that exists in a usefully representative concentration in the fluid sample. For clarity, the present disclosure will discuss the application to glucose monitoring. However, it is to be understood that the invention is not limited to the monitoring of glucose, and that other analytes, as discussed below, can also be measured.
The method utilizes an integrated sampling and analyzing device 10 incorporating a penetration probe 12 capable of penetrating a patient'"'"'s dermal layers to extract an interstitial fluid or whole blood sample, and a method for transferring the sample from the penetration probe 12 to the analysis chamber 20. In one embodiment, the device 12 can be a one-shot disposable device which can be inserted into a meter which communicates with the analysis chamber 20 to perform the analysis of the sample and present and optionally store the result.
In the device 10, a penetration probe 12 for penetrating the subject'"'"'s dermal layers to collect an interstitial fluid or whole blood sample is integrated with an analysis chamber 20. A property of sampling interstitial fluid is that it can take from several to tens of seconds to collect sufficient sample to analyze. This is often not desirable for an analysis chamber 20 wherein the analyte undergoes a reaction as part of the analysis process, as it can be difficult to obtain an accurate start time for the test as well as achieve an even reacting reagent distribution in the sample. In a second aspect of the current invention a method is disclosed for collecting the sample in a pre-chamber 14 and, when full, transferring the sample quickly to an analysis chamber 20.
In this disclosure, unless a different meaning is clear from the context of its usage, “proximal” refers to a region or structure of the device situated toward or adjacent to the dermal surface to be penetrated, and “distal” refers a region or structure of the device situated toward the opposite (non-proximal) end of the device. For example, the penetration probe 12 is at the proximal end of the device.
The Penetration Probe
The penetration probe 12 can be any device capable of penetrating the patient'"'"'s dermal layers to the desired extent and capable of transporting a sample to a pre-chamber 14 or analysis chamber 20. The penetration probe 12 comprises two ends, as illustrated in FIG. 1. The penetrating end 11 of the penetration probe 12 is the end inserted into the dermal layer. The communicating end 13 of the penetration probe 12 is the end which is in communication with either the pre-chamber 14 or the analysis chamber 20.
One or more protrusions 12 with at least one sharp edge or point are suitable as the penetration probe 12. The penetration probe 12 can be fabricated from materials including plastic, metal, glass, ceramic, a composite material (e.g., a composite of ceramic and metal particles), or mixtures and combinations of these materials. The penetration probe 12 can be in the form of a solid protrusion, a needle, a lancet, a tube or a channel. The channel can optionally be open along one or more of its elongated sides. As illustrated in FIG. 2, a preferred embodiment of the penetration probe 12 is two sheets 30 of material formed so as to have a sharply pointed protrusion 12 on each sheet 30 in substantial registration, with the sheets 30 spaced apart such that liquid can be drawn between the sheets 30 by capillary action. In a particularly preferred embodiment, the two sheets 30 of material extend to and overlap with the analysis chamber 20 to form a pre-chamber 14 for sample collection.
When interstitial fluid is sampled, the penetration depth can be controlled by limiting the length the penetration probe 12 protrudes from the proximal surface 34 of the sampling device 10 to less than the thickness of the dermal layer. In a preferred embodiment, the length of the protrusion 12 will be less than 2 to 3 mm, more preferably about 1.5 mm. After penetration to a suitable depth corresponding to the length of the protrusion 12, contact between the surface of the dermal layer and the surface 34 of the analyzing device prevents further penetration. For other uses, such as in sampling interstitial fluid from regions having a thick dermal layer, or for veterinary uses, it can be desirable for the length of the protrusion 12 to be greater than 3 mm. Accordingly, the invention contemplates protrusions 12 of any length, wherein the length is sufficient to sample interstitial fluid. When whole blood is sampled, a slightly longer penetration probe 12 should be used, i.e., one having a length greater than 2 to 3 mm.
The diameter or width of the penetration probe 12 depends upon the design of the penetration probe 12. Suitable diameters or widths are those which provide sufficient sample flow. In the case of a protrusion 12 forming a sharp edge or point, or a tube or channel, the minimum diameter or width is typically greater than about 10 μm. When the penetrating means 12 comprises two sheets 30 in substantial registration, each having a sharply pointed protrusion 12, the two protrusions 12 are typically spaced from 1 mm to 10 μm apart.
The penetration probe 12 can be located on any suitable part of the test strip 10, i.e., an edge 34, a corner 42, or one of the flat surfaces 44. Protection can be provided to the penetration probe 12 by locating it within a recess formed in the distal edge 34 of the test strip 10, as shown in FIG. 3, or in a depression on the surface 44 of the test strip 10. In a preferred embodiment, the recess in the distal edge 34 of the test strip 10 can be configured to substantially align with the shape of a selected dermal surface, e.g., a fingertip. However, the recess can be configured in other suitable shapes, e.g., a square recess, a V-shaped recess, a curved recess, a polygonal recess, and the like. In a preferred embodiment, the penetration probe 12 does not protrude past the proximal-most portion of the proximal edge 34 or surface 44 of the device 10, but when pressed against the skin, the skin deforms into the recess and is punctured by the penetration probe 12. Such an arrangement aids sampling by compressing the area of the skin around the sampling point. The penetration probe 12 can form an integral part of another component of the test strip 10, e.g., a side of the pre-chamber 54, as shown in FIG. 2. Alternatively, the penetration probe 12 can comprise a separate part which is attached to or incorporated into the test strip 10 by any suitable means, e.g., adhesive, thermal bonding, interlocking parts, pressure, and the like. The penetration probe 12 can be retractable or non-retractable.
Penetration itself can be accomplished by any suitable means, including inserting the penetration device 12 manually or by means of a releasable actuator 84 such as, for example, a spring-loaded mechanism 84 as depicted in FIGS. 6a and 6b. Such a spring-loaded mechanism 84 incorporates a spring 86 which is compressed and held in place by a trigger 88 which can release the force compressing the spring 86 when the triggering mechanism is activated. The trigger 88 can be activated manually, or the device 84 can incorporate a pressure sensor which indicates that sufficient pressure has been applied to obtain the sample, thereby activating the trigger 88. In one embodiment, the distal end of the device 10 is placed in the spring-loaded mechanism 84 such that when the force compressing the spring 86 is released by activating the trigger 88, force is transferred to the device 10, which is ejected from the mechanism 84, thereby inserting the penetrating probe 12 into the dermal layer.
Any suitable body part can be used for sampling. In a preferred embodiment, the sampling area is one which does not have a high density of nerve endings, e.g., the forearm. Typically, 5 to 15 seconds is required to obtain sufficient sample. Application of pressure to the sampling area can be needed to extract interstitial fluid or whole blood. To facilitate the appropriate amount of pressure being applied, a pressure sensor can be incorporated into the device 10 which indicates when sufficient pressure has been applied. Sample acquisition time can be improved by applying increased pressure to the area surrounding the direct sampling area. Some of the factors that can affect interstitial fluid or whole blood sample acquisition include the patient'"'"'s age, skin thickness, temperature, and hydration. The amount of interstitial or whole blood sample collected for testing can preferably be about 0.02 μl or greater, more preferably 0.1 μl or greater, and most preferably about 0.5 μl or greater.
In one preferred embodiment, the device 10 can be inserted into a meter prior to sample acquisition. In such an embodiment, the meter serves multiple functions, including supporting the device 10, providing an automated means of initiating sample acquisition, and indicating when sample acquisition is complete.
Transfer of Sample from Penetration Probe to Analysis Chamber
In a preferred embodiment of the sampling device 10, the device comprises two parts—the penetration probe 12 and an analysis chamber 20. In another preferred embodiment, illustrated in FIGS. 1 and 2, the device 10 comprises the penetration probe 12 and a pre-chamber 14. The pre-chamber 14 can then be integrated with or can be interfaced to the analysis chamber 20.
In a further embodiment, the analysis chamber 20 is integrated with or can be interfaced to a means for facilitating filling of the analysis chamber 20. This means can comprise a collapsible or compressible bladder 22, as shown in FIGS. 3 and 4, which can be used to apply a positive or negative pressure (i.e., partial vacuum) to the analysis chamber 20. The compressible bladder 22 can comprise any chamber with flexible walls that can be compressed to reduce the volume of the chamber. When the force compressing the compressible bladder 22 is released, a partial vacuum is formed which draws sample into the analysis chamber 20. In a preferred embodiment, the volume of the compressible bladder 22 is sufficiently large so that when the bladder 22 is substantially fully compressed, the reduction in volume of the bladder 22 is larger than or equal to the total volume of the analysis chamber 20, thereby ensuring that the analysis chamber 20 is substantially filled. However, a compressible bladder 22 with a smaller volume than the analysis chamber 20 can also be effective in assisting the filling of the analysis chamber 20.
Alternatively, the analysis chamber 20 itself can be collapsible or compressible. In such an embodiment, a piston or other compressing agent, such as a patient'"'"'s or clinician'"'"'s fingers, can first compress then release the analysis chamber 20, thereby forming a partial vacuum. When the compressing force is released, the partial vacuum causes the sample to flow from the penetration probe toward the analysis chamber.
Pre-chamber
In a preferred embodiment, as illustrated in FIGS. 1 and 2, a pre-chamber 14 is provided in the integrated sampling and testing device 10 for accumulation and storage of the collected sample prior to its being transferred to the analysis chamber 20. A pre-chamber 14 is useful when using an analysis method which requires that the sample fill the analysis chamber 20 in a short period of time to return accurate results, i.e., a time shorter than that required to draw sufficient sample from the dermal layer. In a preferred embodiment, the volume of the pre-chamber 14 is larger than that of the analysis chamber 20, thus ensuring that once the pre-chamber 14 is filled, sufficient sample has been collected to completely fill the analysis chamber 20.
In a preferred embodiment, as illustrated in FIGS. 1 and 2, the penetration probe 12 opens into the pre-chamber 14 at a first end, and at the second end the pre-chamber 14 opens to the analysis chamber 20. The pre-chamber 14 can be free of reagents or other substances, or can optionally contain one or more substances to enhance or diminish the capillary force exerted by the walls of the pre-chamber 14 or to pre-treat the sample prior to analysis. These substances can include, for example, polymers, resins, powders, meshes, fibrous materials, crystalline materials, porous materials, or a mixture or combination thereof. To facilitate effective filling of the analysis chamber 20, a preferred embodiment utilizes a pre-chamber 14 and analysis chamber 20 of different heights, as shown in FIG. 2. Where the analysis chamber 20 is formed so that its height (typically referring to the smallest chamber dimension) is smaller than the height of the pre-chamber 14, a capillary force is generated that is capable of drawing fluid out of the pre-chamber 14 and into the analysis chamber 20. A first air vent 64 can be formed at the end 70 of the analysis chamber 20 opposite the opening 62 to the pre-chamber 14, facilitating the filling of the analysis chamber 20 by allowing air to be displaced from the analysis chamber 20 as sample enters. Optionally, a second vent 74 can be formed opening into the pre-chamber 14 at the substantially opposite end 60 of the pre-chamber 14 to where the penetration probe 12 opens into the pre-chamber 14. This vent 74 provides air to the pre-chamber 14 to replace the sample as it is transferred from the pre-chamber 14 to the analysis chamber 20. The vent 74 can be placed in any suitable position on the test strip 10. In a preferred embodiment, the vent 74 incorporates a sharp comer, e.g., at a 90° angle, which functions as a “capillary stop” to prevent sample from exiting the device 10 through the vent 74.
In another embodiment, the pre-chamber 14 consists of a tube, or other shaped chamber, with flexible walls, attached to the penetration probe 12. In this embodiment, the pre-chamber 14 is either permanently fixed to the analysis chamber 20 or is placed next to and aligned with a port to the analysis chamber 20. Such alignment can occur during use by suitable placement in an external device such as the measurement meter.
In one aspect of this embodiment, the pre-chamber 14 further comprises a valve, defined as a device to control the flow of fluid sample between the penetration probe 12 and the pre-chamber 14. The valve can comprise one or more rollers, pistons, or squeezing devices capable of simultaneously closing off the first end 60 of the pre-chamber 14, and compressing the pre-chamber 14 such that the fluid in the pre-chamber 14 is forced towards the second end 62 of the pre-chamber 14 and subsequently into the analysis chamber 20.
Alternatively, the analysis chamber 20 consists of a tube, or other shaped chamber, with flexible walls, attached to the penetration probe 12. In one aspect of this embodiment, the analysis chamber 20, prior to penetration, is compressed by one or more rollers, pistons, or other squeezing devices. After the penetration probe 12 is inserted, the compression is released, forming a vacuum which pulls sample into the analysis chamber 20. In such an embodiment, the pre-chamber 14 can not be necessary if sufficient vacuum is generated for rapid sample acquisition. In such an embodiment, the device 10 can not require a vent 64, 74 if such would interfere with forming a vacuum.
In another embodiment, illustrated in FIGS. 3 and 4, a pre-chamber 14 of suitable size is formed which opens to the penetration probe 12 on one end 60 and to the analysis chamber 20 on the other end 62. The end 70 of the analysis chamber 20 opposite to that opening to the pre-chamber 14 opens to a compressible bladder 22. The bladder 22 can be formed separately and attached to the end 70 of the analysis chamber 20. Alternatively, it can be formed by removing a section on the middle laminate 82 in the test strip 10, similar to those described in WO97/00441 (incorporated herein by reference in its entirety), as illustrated in FIGS. 3 and 4.
In use, the bladder 22 in the strip 10 is compressed by suitable means prior to the penetration probe 12 being inserted into the patient. Insertion of the penetration probe 12 can be confirmed by use of a sensor, such as a pressure sensor, or the patient can confirm that the penetration probe 12 is inserted either visually or by touch. In the latter case, the patient sensing can signal the meter, such as by pushing a button. At this point, the means compressing the bladder 22 is withdrawn to a halfway position to draw sample into the pre-chamber 14. When the pre-chamber 14 is full, as indicated by a suitable sensor, the meter indicates to the patient to withdraw the penetration probe 12. The compressing means then moves to its fully withdrawn position and so draws the sample from the pre-chamber 14 into the analysis chamber 20. In the case where the initial suction from the bladder 22 causes the sample to be accumulated with sufficient speed, the pre-chamber 14 can be dispensed with and the bladder 22 used to draw sample through the penetration probe 12 directly into the analysis chamber 20. A vent 64, 74 which would interfere with forming a vacuum need not be incorporated into the device in some embodiments.
Analysis Chamber
In a preferred embodiment, the analysis chamber 20 is contained in an analyzing device 10 comprising a disposable analysis strip similar to that disclosed in WO97/00441. The analysis strip of WO97/00441 contains a biosensor for determining the concentration of an analyte in a carrier, e.g., the concentration of glucose in a fluid sample. The electrochemical analysis cell 20 in this strip has an effective volume of 1.5 μl or less, and can comprise a porous membrane, a working electrode on one side of the membrane, and a counter/reference electrode on the other side. In a preferred embodiment, an analysis cell 20 having an effective volume of about 0.02 μl or greater is used. More preferably, the cell 20 has a volume ranging from about 0.1 μl to about 0.5 μl.
In one aspect of this embodiment, the penetration probe 12 is a small needle integrated into the analysis strip 10 by being inserted through a wall of the analysis chamber 20 such that one end of the needle 12 opens into the strip analysis chamber 20. In using a device 10 having this arrangement to obtain and analyze a sample of interstitial fluid, the needle 12 is inserted into the patient'"'"'s dermal layer and sample is drawn into the needle 12 via capillary action. The sample is then transferred from the needle 12 into the analysis chamber 20 by capillary action whereupon the sample is analyzed. An opening 64 in the analysis chamber 20 to atmosphere, remote from the point where the needle 12 opens into the chamber, acts as a vent 64 to allow the escape of displaced air as the analysis chamber 20 fills with sample. Analysis devices of the type disclosed in WO97/00441 are particularly suited for use with this arrangement because of their ability to utilize the very small volumes of sample typically available with interstitial fluid sampling.
The analysis chamber 20 can contain one or more substances to enhance or diminish the capillary force exerted by the walls of analysis chamber 20. Such materials can include polymers, resins, powders, meshes, fibrous materials, crystalline materials, porous materials, or a mixture or combination thereof, as can also be used in the pre-chamber, discussed above. For example, the walls 24 of the analysis chamber 20 can be coated with a hydrophilic material to encourage the flow of fluid sample into the analysis chamber. Suitable hydrophilic materials include polyethylene glycol, polyvinylpyrrolidone, a surfactant, a hydrophilic block copolymer, and polyacrylic acid. The analysis chamber 20 can also contain reagents capable of reacting with the analyte or other substances present in the sample. Such other substances can include substances which interfere in determining the presence or absence of the analyte. In such cases, the reagent will react with the substance so that it no longer interferes with the analysis.
Any analyte present in a fluid sample in a detectable amount can be analyzed using the device 10. A typical analytes can include, but is not limited to, an ion, an element, a sugar, an alcohol, a hormone, a protein, an enzyme, a cofactor, a nucleic acid sequence, a lipid, and a drug. In a preferred embodiment, glucose is the analyte to be tested. Typical analytes could include, but are not limited to, ethanol, potassium ion, pharmaceuticals, drugs, cholesterol, and lactate.
The presence or absence of the analyte can be determined directly. Alternatively, the analyte can be determined by reacting the analyte with one or more reagents present in the analysis chamber. The product of that reaction, indicative of the presence or absence of the analyte, would then be detected. Suitable reaction products include, but are not limited to, a color indicator, an electric current, an electric potential, an acid, a base, a precipitate, or a gas.
Any suitable analytical method can be used for determining the presence or absence of the analyte or a reaction product of the analyte. Suitable analytical methods include, but are not limited to, electrochemical methods, photoabsorption detection methods, photoemission detection methods, and the measurement of magnetic susceptibility. In the case of a reaction product having a different color than the analyte, or the formation of a precipitate or a gas, a visual determination can be a suitable method for determining the presence or absence of the analyte.
Display/Storage of Measurement Data
In a preferred embodiment, an analysis strip as described above or another embodiment of the sampling device 10 is integrated with a measuring device, e.g., a meter, which can display, store or record test data, optionally in computer-readable format. In such an embodiment, the test strip 10 comprises an interface for communicating with the meter, e.g., conductive leads from the electrodes of the electrochemical cell 20. In the case of obtaining an electrochemical measurement, the interface communicates a voltage or a current to the electrochemical cell 20.
The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention as embodied in the attached claims.